Personalized Medicine Market is expected to reach US$ 848.01 Bn. at a CAGR of 6.21% during the forecast period 2029.Personalized Medicine Market Overview:
The Personalized medicine is an emerging field of, medicine which is also referred to as precision medicine. This medical model uses an individual’s genetic profile to guide decisions made in regard to the prevention, diagnosis, and treatment of disease. Knowledge of a patient's genetic profile can help doctors select the proper medication or therapy and administer it using the proper dose or regimen. Personalized medicine is being advanced through data from the Human Genome Project.To know about the Research Methodology :- Request Free Sample Report
Personalized Medicine Market Dynamics:
Dominantly increasing cases of various cancers worldwide primarily drive the market growth. The rising prevalence of cancer and the rising demand for personalized cancer therapeutics boost the market growth. Growing incidences of technological advancements owing to the accessibility of large scale human genome databases including Next Generation Sequencing (NGS) positively impacts market growth. The use of advanced computational tools and the development of innovative genetic technologies help in identifying cancer causes. Recent developments in pharmacogenomics are expected to create a suitable environment for developing drugs, which are specific to one patient or group. Increasing therapeutic applications in the fields like cardio-renal, neurology, antiviral, pulmonary, psychiatry are expected to create potential growth opportunity in forecast years. However, complex nature of these drugs, high development costs, and variability effects amongst the patients are some factors that may restrain the market growth. The report has profiled eighteen key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed.Personalized Medicine Market Segment Analysis:
The global Personalized Medicine Market is segment on the basis of product, application, technology and end-users. Based on Product, the personalized nutrition & wellness segment held the largest share of xx% in 2022. It is expected to grow at a CAGR of 8.3% during the forecast period. Rising awareness of consuming healthy food for wellness, an increase in adoption of customized diet plans are considered to be the major factors propelling the segment growth. A wide range of nutrition & wellness products are available which play a significant role in boosting segment growth. In March 2021, DSM partnered with Mixfit to provide personalized nutrition solutions by combining Artificial Intelligence (AI) technology. Based on Technology, the drug discovery segment is expected to dominate the global market. Recent technological advancements in drug discovery and pharmacogenomics contribute to boosting the market growth. Pharmacogenomics is used in predicting the efficacy of a drug. Pharmacogenomics helps in focusing effective therapy on smaller patient subpopulations that, although demonstrate the same disease phenotype but have distinct genetic profiles. The segment is estimated to grow at a CAGR of 8.7% during the forecast period. In October 2021, Qiagen announced its launch of novel RNA-seq library preparation solutions for next-generation sequencing thereby expanding its portfolio and user base significantly.Regional Insights:
North America held a prominent market share of xx% in 2022. Due to Huge investments in the healthcare industry, the market for personalized medicine is expected to be dominated by the North America region followed by Europe. The increasing prevalence of cancer in the region and increased demand for precision medicine is attributed to the favorable government initiatives and growing investments for the development of novel solutions for effective disease management. Various initiatives undertaken will pave the market growth by creating awareness about personalized medicines.APAC is expected to grow at a significant CAGR during forecast period.
Owing to the low cost of clinical trials of newly developed precision medicines and diagnostic products. Moreover, rising disposable income levels and the growing economy of emerging countries will boost the market further. The report also helps in understanding Global Personalized Medicine Market dynamics, structure by analyzing the market segments and project the Global Personalized Medicine Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Personalized Medicine Market make the report investor’s guide.Personalized Medicine Market Scope: Inquire before buying
Global Personalized Medicine Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 556.21 Bn. Forecast Period 2023 to 2029 CAGR: 6.21% Market Size in 2029: US $ 848.01 Bn. Segments Covered: by Product Personalized Medical Care Therapeutics Personalized Nutrition & Wellness by Application Oncology Immunology CNS Respiratory by Technology Big Data Analytics Bioinformatics Gene Sequencing Drug Discovery Companion Diagnostics by End users Pharmaceutical Companies Diagnostic Companies Healthcare IT companies Personalized Medicine Market, by Region:
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Key Players
1. Abbott Laboratories 2. Merck & Co., Inc. 3. AstraZeneca 4. Pfizer, Inc. 5. GlaxoSmithKline plc. 6. Novartis AG 7. Amgen, Inc. 8. Bayer AG 9. Mylan N.V. 10. Eli Lilly and Company 11. Bristol Myers Squibb Co. 12. Daiichi Sankyo Company, Ltd. 13. Biogen, Inc. 14. Johnson & Johnson Services, Inc. 15. F. Hoffmann-La Roche Ltd. 16. Thermo Fisher Scientific, Inc. 17. Novo Nordisk A/S 18. Sanofi Genzyme.Frequently Asked Questions:
1. Which region has the largest share in Global Personalized Medicine Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Personalized Medicine Market? Ans: The Global Personalized Medicine Market is expected to grow at a CAGR of 6.21% during forecast period 2023-2029. 3. What is scope of the Global Personalized Medicine market report? Ans: Global Personalized Medicine Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Personalized Medicine market? Ans: The important key players in the Global Personalized Medicine Market are – Abbott Laboratories, Merck & Co., Inc., AstraZeneca, Pfizer, Inc., GlaxoSmithKline plc., Novartis AG, Amgen, Inc., Bayer AG, Mylan N.V., Eli Lilly and Company, Bristol Myers Squibb Co., Daiichi Sankyo Company, Ltd., Biogen, Inc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Novo Nordisk A/S, and Sanofi Genzyme.. 5. What is the study period of this market? Ans: The Global Personalized Medicine Market is studied from 2022 to 2029.
1. Personalized Medicine Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Personalized Medicine Market: Dynamics 2.1. Market Trends by Region 2.1.1. North America 2.1.2. Europe 2.1.3. Asia Pacific 2.1.4. Middle East and Africa 2.1.5. South America 2.2. Market Dynamics by Region 2.2.1. North America 2.2.1.1. Drivers 2.2.1.2. Restraints 2.2.1.3. Opportunities 2.2.1.4. Challenges 2.2.2. Europe 2.2.2.1. Drivers 2.2.2.2. Restraints 2.2.2.3. Opportunities 2.2.2.4. Challenges 2.2.3. Asia Pacific 2.2.3.1. Drivers 2.2.3.2. Restraints 2.2.3.3. Opportunities 2.2.3.4. Challenges 2.2.4. Middle East and Africa 2.2.4.1. Drivers 2.2.4.2. Restraints 2.2.4.3. Opportunities 2.2.4.4. Challenges 2.2.5. South America 2.2.5.1. Drivers 2.2.5.2. Restraints 2.2.5.3. Opportunities 2.2.5.4. Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Value Chain Analysis 2.6. Technological Roadmap 2.7. Regulatory Landscape by Region 2.7.1. North America 2.7.2. Europe 2.7.3. Asia Pacific 2.7.4. Middle East and Africa 2.7.5. South America 2.8. Analysis of Government Schemes and Initiatives For Personalized Medicine Industry 2.9. Key Opinion Leader Analysis 2.10. The Global Pandemic Impact on Personalized Medicine Market 2.11. Growth of Digital Health Platforms 2.12. Artificial Intelligence in Personalized Medicine 3. Personalized Medicine Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 3.1. Personalized Medicine Market Size and Forecast, By Product (2023-2030) 3.1.1. Personalized Medical Care 3.1.2. Therapeutics 3.1.3. Personalized Nutrition & Wellness 3.2. Personalized Medicine Market Size and Forecast, By Application (2023-2030) 3.2.1. Oncology 3.2.2. Immunology 3.2.3. CNS 3.2.4. Respiratory 3.3. Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 3.3.1. Big Data Analytics 3.3.2. Bioinformatics 3.3.3. Gene Sequencing 3.3.4. Drug Discovery 3.3.5. Companion Diagnostics 3.4. Personalized Medicine Market Size and Forecast, By End users (2023-2030) 3.4.1. Pharmaceutical Companies 3.4.2. Diagnostic Companies 3.4.3. Healthcare IT companies 3.5. Personalized Medicine Market Size and Forecast, By Region (2023-2030) 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. Middle East and Africa 3.5.5. South America 4. North America Personalized Medicine Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 4.1. North America Personalized Medicine Market Size and Forecast, By Product (2023-2030) 4.1.1. Personalized Medical Care 4.1.2. Therapeutics 4.1.3. Personalized Nutrition & Wellness 4.2. North America Personalized Medicine Market Size and Forecast, By Application (2023-2030) 4.2.1. Oncology 4.2.2. Immunology 4.2.3. CNS 4.2.4. Respiratory 4.3. North America Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 4.3.1. Big Data Analytics 4.3.2. Bioinformatics 4.3.3. Gene Sequencing 4.3.4. Drug Discovery 4.3.5. Companion Diagnostics 4.4. North America Personalized Medicine Market Size and Forecast, By End users (2023-2030) 4.4.1. Pharmaceutical Companies 4.4.2. Diagnostic Companies 4.4.3. Healthcare IT companies 4.5. North America Personalized Medicine Market Size and Forecast, by Country (2023-2030) 4.5.1. United States 4.5.1.1. United States Personalized Medicine Market Size and Forecast, By Product (2023-2030) 4.5.1.1.1.1. Personalized Medical Care 4.5.1.1.1.2. Therapeutics 4.5.1.1.1.3. Personalized Nutrition & Wellness 4.5.1.2. United States Personalized Medicine Market Size and Forecast, By Application (2023-2030) 4.5.1.2.1. Oncology 4.5.1.2.2. Immunology 4.5.1.2.3. CNS 4.5.1.2.4. Respiratory 4.5.1.3. United States Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 4.5.1.3.1. Big Data Analytics 4.5.1.3.2. Bioinformatics 4.5.1.3.3. Gene Sequencing 4.5.1.3.4. Drug Discovery 4.5.1.3.5. Companion Diagnostics 4.5.1.4. United States Personalized Medicine Market Size and Forecast, By End users (2023-2030) 4.5.1.4.1. Pharmaceutical Companies 4.5.1.4.2. Diagnostic Companies 4.5.1.4.3. Healthcare IT companies 4.5.2. Canada 4.5.2.1. Canada Personalized Medicine Market Size and Forecast, By Product (2023-2030) 4.5.2.1.1. Personalized Medical Care 4.5.2.1.2. Therapeutics 4.5.2.1.3. Personalized Nutrition & Wellness 4.5.2.2. Canada Personalized Medicine Market Size and Forecast, By Application (2023-2030) 4.5.2.2.1. Oncology 4.5.2.2.2. Immunology 4.5.2.2.3. CNS 4.5.2.2.4. Respiratory 4.5.2.3. Canada Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 4.5.2.3.1. Big Data Analytics 4.5.2.3.2. Bioinformatics 4.5.2.3.3. Gene Sequencing 4.5.2.3.4. Drug Discovery 4.5.2.3.5. Companion Diagnostics 4.5.2.4. Canada Personalized Medicine Market Size and Forecast, By End users (2023-2030) 4.5.2.4.1. Pharmaceutical Companies 4.5.2.4.2. Diagnostic Companies 4.5.2.4.3. Healthcare IT companies 4.5.3. Mexico 4.5.3.1. Mexico Personalized Medicine Market Size and Forecast, By Product (2023-2030) 4.5.3.1.1. Personalized Medical Care 4.5.3.1.2. Therapeutics 4.5.3.1.3. Personalized Nutrition & Wellness 4.5.3.2. Mexico Personalized Medicine Market Size and Forecast, By Application (2023-2030) 4.5.3.2.1. Oncology 4.5.3.2.2. Immunology 4.5.3.2.3. CNS 4.5.3.2.4. Respiratory 4.5.3.3. Mexico Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 4.5.3.3.1. Big Data Analytics 4.5.3.3.2. Bioinformatics 4.5.3.3.3. Gene Sequencing 4.5.3.3.4. Drug Discovery 4.5.3.3.5. Companion Diagnostics 4.5.3.4. Mexico Personalized Medicine Market Size and Forecast, By End users (2023-2030) 4.5.3.4.1. Pharmaceutical Companies 4.5.3.4.2. Diagnostic Companies 4.5.3.4.3. Healthcare IT companies 5. Europe Personalized Medicine Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 5.1. Europe Personalized Medicine Market Size and Forecast, By Product (2023-2030) 5.2. Europe Personalized Medicine Market Size and Forecast, By Application (2023-2030) 5.3. Europe Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 5.4. Europe Personalized Medicine Market Size and Forecast, By End users (2023-2030) 5.5. Europe Personalized Medicine Market Size and Forecast, by Country (2023-2030) 5.5.1. United Kingdom 5.5.1.1. United Kingdom Personalized Medicine Market Size and Forecast, By Product (2023-2030) 5.5.1.2. United Kingdom Personalized Medicine Market Size and Forecast, By Application (2023-2030) 5.5.1.3. United Kingdom Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 5.5.1.4. United Kingdom Personalized Medicine Market Size and Forecast, By End users (2023-2030) 5.5.2. France 5.5.2.1. France Personalized Medicine Market Size and Forecast, By Product (2023-2030) 5.5.2.2. France Personalized Medicine Market Size and Forecast, By Application (2023-2030) 5.5.2.3. France Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 5.5.2.4. France Personalized Medicine Market Size and Forecast, By End users (2023-2030) 5.5.3. Germany 5.5.3.1. Germany Personalized Medicine Market Size and Forecast, By Product (2023-2030) 5.5.3.2. Germany Personalized Medicine Market Size and Forecast, By Application (2023-2030) 5.5.3.3. Germany Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 5.5.3.4. Germany Personalized Medicine Market Size and Forecast, By End users (2023-2030) 5.5.4. Italy 5.5.4.1. Italy Personalized Medicine Market Size and Forecast, By Product (2023-2030) 5.5.4.2. Italy Personalized Medicine Market Size and Forecast, By Application (2023-2030) 5.5.4.3. Italy Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 5.5.4.4. Italy Personalized Medicine Market Size and Forecast, By End users (2023-2030) 5.5.5. Spain 5.5.5.1. Spain Personalized Medicine Market Size and Forecast, By Product (2023-2030) 5.5.5.2. Spain Personalized Medicine Market Size and Forecast, By Application (2023-2030) 5.5.5.3. Spain Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 5.5.5.4. Spain Personalized Medicine Market Size and Forecast, By End users (2023-2030) 5.5.6. Sweden 5.5.6.1. Sweden Personalized Medicine Market Size and Forecast, By Product (2023-2030) 5.5.6.2. Sweden Personalized Medicine Market Size and Forecast, By Application (2023-2030) 5.5.6.3. Sweden Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 5.5.6.4. Sweden Personalized Medicine Market Size and Forecast, By End users (2023-2030) 5.5.7. Austria 5.5.7.1. Austria Personalized Medicine Market Size and Forecast, By Product (2023-2030) 5.5.7.2. Austria Personalized Medicine Market Size and Forecast, By Application (2023-2030) 5.5.7.3. Austria Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 5.5.7.4. Austria Personalized Medicine Market Size and Forecast, By End users (2023-2030) 5.5.8. Rest of Europe 5.5.8.1. Rest of Europe Personalized Medicine Market Size and Forecast, By Product (2023-2030) 5.5.8.2. Rest of Europe Personalized Medicine Market Size and Forecast, By Application (2023-2030) 5.5.8.3. Rest of Europe Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 5.5.8.4. Rest of Europe Personalized Medicine Market Size and Forecast, By End users (2023-2030) 6. Asia Pacific Personalized Medicine Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 6.1. Asia Pacific Personalized Medicine Market Size and Forecast, By Product (2023-2030) 6.2. Asia Pacific Personalized Medicine Market Size and Forecast, By Application (2023-2030) 6.3. Asia Pacific Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 6.4. Asia Pacific Personalized Medicine Market Size and Forecast, By End users (2023-2030) 6.5. Asia Pacific Personalized Medicine Market Size and Forecast, by Country (2023-2030) 6.5.1. China 6.5.1.1. China Personalized Medicine Market Size and Forecast, By Product (2023-2030) 6.5.1.2. China Personalized Medicine Market Size and Forecast, By Application (2023-2030) 6.5.1.3. China Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 6.5.1.4. China Personalized Medicine Market Size and Forecast, By End users (2023-2030) 6.5.2. S Korea 6.5.2.1. S Korea Personalized Medicine Market Size and Forecast, By Product (2023-2030) 6.5.2.2. S Korea Personalized Medicine Market Size and Forecast, By Application (2023-2030) 6.5.2.3. S Korea Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 6.5.2.4. S Korea Personalized Medicine Market Size and Forecast, By End users (2023-2030) 6.5.3. Japan 6.5.3.1. Japan Personalized Medicine Market Size and Forecast, By Product (2023-2030) 6.5.3.2. Japan Personalized Medicine Market Size and Forecast, By Application (2023-2030) 6.5.3.3. Japan Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 6.5.3.4. Japan Personalized Medicine Market Size and Forecast, By End users (2023-2030) 6.5.4. India 6.5.4.1. India Personalized Medicine Market Size and Forecast, By Product (2023-2030) 6.5.4.2. India Personalized Medicine Market Size and Forecast, By Application (2023-2030) 6.5.4.3. India Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 6.5.4.4. India Personalized Medicine Market Size and Forecast, By End users (2023-2030) 6.5.5. Australia 6.5.5.1. Australia Personalized Medicine Market Size and Forecast, By Product (2023-2030) 6.5.5.2. Australia Personalized Medicine Market Size and Forecast, By Application (2023-2030) 6.5.5.3. Australia Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 6.5.5.4. Australia Personalized Medicine Market Size and Forecast, By End users (2023-2030) 6.5.6. Indonesia 6.5.6.1. Indonesia Personalized Medicine Market Size and Forecast, By Product (2023-2030) 6.5.6.2. Indonesia Personalized Medicine Market Size and Forecast, By Application (2023-2030) 6.5.6.3. Indonesia Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 6.5.6.4. Indonesia Personalized Medicine Market Size and Forecast, By End users (2023-2030) 6.5.7. Malaysia 6.5.7.1. Malaysia Personalized Medicine Market Size and Forecast, By Product (2023-2030) 6.5.7.2. Malaysia Personalized Medicine Market Size and Forecast, By Application (2023-2030) 6.5.7.3. Malaysia Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 6.5.7.4. Malaysia Personalized Medicine Market Size and Forecast, By End users (2023-2030) 6.5.8. Vietnam 6.5.8.1. Vietnam Personalized Medicine Market Size and Forecast, By Product (2023-2030) 6.5.8.2. Vietnam Personalized Medicine Market Size and Forecast, By Application (2023-2030) 6.5.8.3. Vietnam Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 6.5.8.4. Vietnam Personalized Medicine Market Size and Forecast, By End users (2023-2030) 6.5.9. Taiwan 6.5.9.1. Taiwan Personalized Medicine Market Size and Forecast, By Product (2023-2030) 6.5.9.2. Taiwan Personalized Medicine Market Size and Forecast, By Application (2023-2030) 6.5.9.3. Taiwan Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 6.5.9.4. Taiwan Personalized Medicine Market Size and Forecast, By End users (2023-2030) 6.5.10. Rest of Asia Pacific 6.5.10.1. Rest of Asia Pacific Personalized Medicine Market Size and Forecast, By Product (2023-2030) 6.5.10.2. Rest of Asia Pacific Personalized Medicine Market Size and Forecast, By Application (2023-2030) 6.5.10.3. Rest of Asia Pacific Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 6.5.10.4. Rest of Asia Pacific Personalized Medicine Market Size and Forecast, By End users (2023-2030) 7. Middle East and Africa Personalized Medicine Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 7.1. Middle East and Africa Personalized Medicine Market Size and Forecast, By Product (2023-2030) 7.2. Middle East and Africa Personalized Medicine Market Size and Forecast, By Application (2023-2030) 7.3. Middle East and Africa Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 7.4. Middle East and Africa Personalized Medicine Market Size and Forecast, By End users (2023-2030) 7.5. Middle East and Africa Personalized Medicine Market Size and Forecast, by Country (2023-2030) 7.5.1. South Africa 7.5.1.1. South Africa Personalized Medicine Market Size and Forecast, By Product (2023-2030) 7.5.1.2. South Africa Personalized Medicine Market Size and Forecast, By Application (2023-2030) 7.5.1.3. South Africa Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 7.5.1.4. South Africa Personalized Medicine Market Size and Forecast, By End users (2023-2030) 7.5.2. GCC 7.5.2.1. GCC Personalized Medicine Market Size and Forecast, By Product (2023-2030) 7.5.2.2. GCC Personalized Medicine Market Size and Forecast, By Application (2023-2030) 7.5.2.3. GCC Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 7.5.2.4. GCC Personalized Medicine Market Size and Forecast, By End users (2023-2030) 7.5.3. Nigeria 7.5.3.1. Nigeria Personalized Medicine Market Size and Forecast, By Product (2023-2030) 7.5.3.2. Nigeria Personalized Medicine Market Size and Forecast, By Application (2023-2030) 7.5.3.3. Nigeria Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 7.5.3.4. Nigeria Personalized Medicine Market Size and Forecast, By End users (2023-2030) 7.5.4. Rest of ME&A 7.5.4.1. Rest of ME&A Personalized Medicine Market Size and Forecast, By Product (2023-2030) 7.5.4.2. Rest of ME&A Personalized Medicine Market Size and Forecast, By Application (2023-2030) 7.5.4.3. Rest of ME&A Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 7.5.4.4. Rest of ME&A Personalized Medicine Market Size and Forecast, By End users (2023-2030) 8. South America Personalized Medicine Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) (2023-2030) 8.1. South America Personalized Medicine Market Size and Forecast, By Product (2023-2030) 8.2. South America Personalized Medicine Market Size and Forecast, By Application (2023-2030) 8.3. South America Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 8.4. South America Personalized Medicine Market Size and Forecast, By End users (2023-2030) 8.5. South America Personalized Medicine Market Size and Forecast, by Country (2023-2030) 8.5.1. Brazil 8.5.1.1. Brazil Personalized Medicine Market Size and Forecast, By Product (2023-2030) 8.5.1.2. Brazil Personalized Medicine Market Size and Forecast, By Application (2023-2030) 8.5.1.3. Brazil Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 8.5.1.4. Brazil Personalized Medicine Market Size and Forecast, By End users (2023-2030) 8.5.2. Argentina 8.5.2.1. Argentina Personalized Medicine Market Size and Forecast, By Product (2023-2030) 8.5.2.2. Argentina Personalized Medicine Market Size and Forecast, By Application (2023-2030) 8.5.2.3. Argentina Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 8.5.2.4. Argentina Personalized Medicine Market Size and Forecast, By End users (2023-2030) 8.5.3. Rest Of South America 8.5.3.1. Rest Of South America Personalized Medicine Market Size and Forecast, By Product (2023-2030) 8.5.3.2. Rest Of South America Personalized Medicine Market Size and Forecast, By Application (2023-2030) 8.5.3.3. Rest Of South America Personalized Medicine Market Size and Forecast, By Technology (2023-2030) 8.5.3.4. Rest Of South America Personalized Medicine Market Size and Forecast, By End users (2023-2030) 9. Global Personalized Medicine Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Service Segment 9.3.3. Deployment Type Segment 9.3.4. Revenue (2023) 9.3.5. Manufacturing Locations 9.4. Leading Personalized Medicine Market Companies, by Market Capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Abbott Laboratories 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Developments 10.2. FMC Technologies, Inc (US) 10.3. Merck & Co., Inc. 10.4. AstraZeneca 10.5. Pfizer, Inc. 10.6. GlaxoSmithKline plc. 10.7. Novartis AG 10.8. Amgen, Inc. 10.9. Bayer AG 10.10. Mylan N.V. 10.11. Eli Lilly and Company 10.12. Bristol Myers Squibb Co. 10.13. Daiichi Sankyo Company, Ltd. 10.14. Biogen, Inc. 10.15. Johnson & Johnson Services, Inc. 10.16. F. Hoffmann-La Roche Ltd. 10.17. Thermo Fisher Scientific, Inc. 10.18. Novo Nordisk A/S 10.19. Sanofi Genzyme. 11. Key Findings 12. Industry Recommendations 13. Personalized Medicine Market: Research Methodology